TESARO INC's ticker is TSRO and the CUSIP is 881569107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,156,000 | -22.2% | 26,000 | 0.0% | 0.05% | -31.4% |
| Q1 2018 | $1,486,000 | -31.0% | 26,000 | 0.0% | 0.07% | -37.5% |
| Q4 2017 | $2,155,000 | -35.8% | 26,000 | 0.0% | 0.11% | -41.1% |
| Q3 2017 | $3,357,000 | -7.7% | 26,000 | 0.0% | 0.19% | -15.9% |
| Q2 2017 | $3,636,000 | -9.1% | 26,000 | 0.0% | 0.23% | -14.7% |
| Q1 2017 | $4,001,000 | -54.2% | 26,000 | -60.0% | 0.26% | -53.4% |
| Q4 2016 | $8,741,000 | +16.3% | 65,000 | -13.3% | 0.57% | +24.0% |
| Q3 2016 | $7,518,000 | -0.6% | 75,000 | -16.7% | 0.46% | -0.9% |
| Q2 2016 | $7,565,000 | -4.5% | 90,000 | -50.0% | 0.46% | +4.5% |
| Q1 2016 | $7,925,000 | -15.9% | 180,000 | 0.0% | 0.44% | -5.9% |
| Q4 2015 | $9,418,000 | +39.8% | 180,000 | +7.1% | 0.47% | +20.5% |
| Q3 2015 | $6,737,000 | -0.7% | 168,000 | +45.6% | 0.39% | +6.5% |
| Q2 2015 | $6,784,000 | +34.8% | 115,400 | +31.6% | 0.37% | -3.2% |
| Q1 2015 | $5,034,000 | +80.5% | 87,700 | +16.9% | 0.38% | +24.7% |
| Q4 2014 | $2,789,000 | – | 75,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 9,854,255 | $565,634,000 | 25.58% |
| Perceptive Advisors | 978,359 | $56,158,000 | 4.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 556,379 | $31,936,000 | 4.05% |
| HealthCor Management, L.P. | 925,000 | $53,095,000 | 2.53% |
| Monashee Investment Management LLC | 50,000 | $2,870,000 | 1.79% |
| Cormorant Asset Management, LP | 191,250 | $10,978,000 | 1.70% |
| BB BIOTECH AG | 854,582 | $49,053,000 | 1.46% |
| HealthCor Management, L.P. | 500,000 | $28,700,000 | 1.37% |
| Rock Springs Capital Management LP | 210,000 | $12,054,000 | 1.13% |
| Orbimed Advisors | 2,057,700 | $118,112,000 | 1.01% |